Rayence Co., Ltd. (KOSDAQ:228850)

Market Cap	103.70B
Revenue (ttm)	125.56B
Net Income (ttm)	7.83B
Shares Out	15.74M
EPS (ttm)	497.54
PE Ratio	13.25
Forward PE	9.41
Dividend	100.00 (1.52%)
Ex-Dividend Date	Dec 27, 2024

Volume	2,709
Average Volume	4,799
Open	6,460.00
Previous Close	6,460.00
Day's Range	6,400.00 - 6,500.00
52-Week Range	5,620.00 - 9,060.00
Beta	0.87
RSI	66.42
Earnings Date	May 8, 2025

About Rayence

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides rad...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 2011
• Employees: 224
• Stock Exchange: KOSDAQ
• Ticker Symbol: 228850

Financial Performance

In 2024, Rayence's revenue was 125.56 billion, a decrease of -12.18% compared to the previous year's 142.99 billion. Earnings were 7.83 billion, a decrease of -60.05%.